Cagrilintide is a long-acting synthetic peptide that targets amylin and glucagon receptors, making it a key compound in studies related to satiety signaling, energy balance, and weight regulation. It is structurally related to endogenous amylin and is often studied in combination with GLP-1 receptor agonists such as Semaglutide to enhance appetite suppression and metabolic effects.
Key Research Areas:
Appetite regulation and satiety signaling
Body weight control and fat metabolism
Delayed gastric emptying and food intake reduction
Combination studies with GLP-1 analogs (e.g. Semaglutide, Tirzepatide)
Obesity and metabolic syndrome models